Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Agonists of the GLP-1 receptor have been developed to treat type 2 diabetes, and recent studies suggest that such agonists may also have important effects in the control of obesity1, 2
Metabolic reprogramming in colorectal cancer: a review of aerobic glycolysis and its therapeutic implications for targeted treatment strategies
GIP receptor activation enhances glucose-dependent insulin secretion, promotes pancreatic beta-cell survival, and may contribute to improved lipid metabolism
Jul 2025;35(4):531-538
S., Wu, J
US$ 26.47
US$ 26.50
US$ 27.92
US$ 25.21
US$ 29.72
US$ 24.46
US$ 22.50
